PofoliaPofolia ile paylaşıldı

BMC Complementary Medicine and Therapies· 2026Q1

Geleneksel Fas bitki çaylarının tip 2 diyabet yönetimindeki etnofarmakolojik içgörüleri: Fenolik bileşiklerin HPLC-MS ile karakterizasyonu ve ilgili antioksidan ve enzim inhibisyon aktiviteleri

Ethnopharmacological insights into type 2 diabetes management by traditional Moroccan herbal teas: HPLC-MS characterization of phenolic compounds and their related antioxidant and enzyme inhibitory activities

Ahmed Mohamed zayed, Meryem El Jemli, Mourad Kharbach, My El Abbes Faouzi ve diğerleri

Kısa özet

Glikemik kontrol için kullanılan 21 geleneksel Fas bitki çayı, fenolik içerikleriyle ilişkili değişken antioksidan ve karbonhidrat sindirim enzimi inhibisyon aktiviteleri göstermiştir; Pelargonium graveolens ve Mentha viridis sırasıyla güçlü α-amilaz ve α-glukozidaz inhibisyonu sergilemiştir.

Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.

Ana noktalar

  • Glikemik kontrol için kullanılan yirmi bir geleneksel Fas bitki çayı, fenolik içerik, antioksidan aktivite ve α-amilaz ile α-glukozidaz inhibisyonu açısından analiz edilmiştir.
  • Mentha × piperita ve Thymus broussonetii en yüksek toplam fenolik içeriğe sahipti (sırasıyla 883.2 ve 746.8 mg GAE/g kuru ağırlık).
  • Pelargonium graveolens güçlü α-amilaz inhibisyonu gösterdi (IC50 = 2.98 µg/mL).
  • Mentha viridis ve Calamintha officinalis en aktif α-glukozidaz inhibitörleriydi (IC50 = 1.9 ve 1.2 µg/mL).
  • Toplam fenolik içerik, antioksidan aktivite ile güçlü bir şekilde ilişkiliydi (r = 0.93–0.96).

Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.

Özet (abstract)

Abstract Background Traditional Moroccan herbal teas are widely consumed and have been traditionally used for managing chronic metabolic disorders, particularly type 2 diabetes mellitus (T2DM). Although these preparations have a long history of ethnomedicinal use, their phenolic composition and biological activities remain insufficiently characterized. Scientific validation is needed to support their traditional application and provide evidence for their potential relevance to T2DM management. This study aimed to characterize the phenolic profile, antioxidant potential, and carbohydrate-digestive enzyme inhibitory activity of 21 traditional Moroccan herbal teas used for glycaemic control. Methods Phenolic constituents were identified and quantified using HPLC-MS. Antioxidant capacity was evaluated through DPPH, ABTS, and FRAP assays. Inhibitory effects on α -amylase and α -glucosidase were assessed in vitro. Correlation analyses were conducted to explore associations between phenolic constituents and biological activities. Findings Marked variability in total phenolic content (TPC) was observed, with Mentha × piperita and Thymus broussonetii exhibiting the highest levels at 883.2 ± 13.0 and 746.8 ± 22.4 mg GAE/g dry weight, respectively. Antioxidant activity varied substantially among the investigated teas, with T. broussonetii (FRAP reducing power: 423.6 ± 9.8 µg/mL) and Mentha rotundifolia (162.6 ± 0.6 µg/mL) showing significant reducing capacities. TPC exhibited strong positive correlations with antioxidant indices ( r = 0.93–0.96). Pelargonium graveolens presented potent α -amylase inhibition (IC 50 = 2.98 ± 1.7 µg/mL), whereas Mentha viridis and Calamintha officinalis were among the most active α -glucosidase inhibitors (IC 50 = 1.9 ± 0.4 and 1.2 ± 0.1 µg/mL, respectively). Negative correlations were found between rutin ( r = − 0.49) and gallic acid ( r = − 0.44) contents and α -amylase IC 50 values. Conclusion The investigated Moroccan herbal teas exhibited variable antioxidant and digestive-enzyme inhibitory activities that were associated with their phenolic composition. Variability among samples may reflect differences in plant species and environmental or agronomic factors. These findings provide comparative in vitro evidence supporting the traditional use of Moroccan herbal teas and highlight several species as promising sources of bioactive phenolics. However, the present findings do not establish therapeutic efficacy, and further in vivo, mechanistic, pharmacokinetic, and clinical studies are required to confirm their efficacy, safety, and clinical relevance.

Yazarların özeti; kaynağından alınmıştır. BMC Complementary Medicine and Therapies, 2026 · DOI ↗

ÇıkarımlarPremium
Makaleye SorÜcretsiz hesapla

Ücretsiz hesapla devam et

Makaleye Sor ile bu makaleye günde 3 soru ücretsiz; makaleyi kaydet, kaynakçasını al, ilgi alanına göre her gün yeni özetler. Çıkarımlar Premium.

Web'de ücretsiz devam et

Google ya da Apple hesabınla giriş; kart istemez. Bu makaleye geri dönersin.

Telefonda:

Alan: Biyokimya (Tıp)

BiochemistryMedicine